Related Experiment Videos
Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy
N C Notermans1, H Franssen, M Eurelings
1Department of Neuromuscular Disorders, Rudolf Magnus Institute of Neurosciences, PO Box 85500, 3508 GA Utrecht, The Netherlands. N.C.Notermans@neuro.azu.nl
Abstract:
In order to define diagnostic criteria for the demyelinating polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS), we compared 30 patients with idiopathic chronic inflammatory demyelinating polyneuropathy (CIDP) without a monoclonal gammopathy, with 29 patients with polyneuropathy associated with MGUS. All 59 patients fulfilled research criteria for CIDP. In the patients with MGUS, sensory symptoms and signs predominated, there was usually no cranial nerve involvement, and the neuropathy was symmetrical with a slowly progressive course. On electrophysiological examination, an abnormal median nerve sensory action potential in combination with a normal sural nerve action potential (AMNS) was not found. In idiopathic CIDP patients, a preceding infection was frequent, motor features predominated, there was often cranial nerve involvement, the neuropathy could be asymmetrical, and AMNS was frequently found. Diagnostic criteria for demyelinating polyneuropathy associated with MGUS are presented.
Insights
Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy of undetermined significance (MGUS) were defined by comparing patients with MGUS to those with idiopathic chronic inflammatory demyelinating polyneuropathy (CIDP). Key differences in symptoms, progression, and electrophysiology were identified.
Area of Science:
- Neurology
- Clinical Electrophysiology
- Immunology
Background:
- Monoclonal gammopathy of undetermined significance (MGUS) is associated with various neuropathies.
- Demyelinating polyneuropathies in MGUS require specific diagnostic criteria.
- Distinguishing MGUS-associated demyelinating polyneuropathy from idiopathic chronic inflammatory demyelinating polyneuropathy (CIDP) is clinically important.
Purpose of the Study:
- To establish diagnostic criteria for demyelinating polyneuropathy associated with MGUS.
- To differentiate MGUS-associated polyneuropathy from idiopathic CIDP.
- To identify distinct clinical and electrophysiological features of each condition.
Main Methods:
- Comparative study of 59 patients: 30 with idiopathic CIDP and 29 with MGUS-associated polyneuropathy.
- All patients met research criteria for CIDP.
- Analysis of clinical presentation (symptoms, signs, progression) and electrophysiological findings.
Main Results:
- MGUS-associated polyneuropathy predominantly featured sensory symptoms, symmetry, slow progression, and lacked cranial nerve involvement.
- Idiopathic CIDP often presented with motor features, asymmetry, cranial nerve involvement, and preceding infections.
- A specific electrophysiological finding (abnormal median nerve sensory action potential with normal sural nerve action potential) was absent in MGUS patients but frequent in idiopathic CIDP.
Conclusions:
- Distinct clinical and electrophysiological profiles differentiate MGUS-associated demyelinating polyneuropathy from idiopathic CIDP.
- The study presents proposed diagnostic criteria for MGUS-associated demyelinating polyneuropathy.
- Understanding these differences aids in accurate diagnosis and management of patients with monoclonal gammopathies and neuropathy.